Skip to main content
. 2018 Nov 23;34(2):309–317. doi: 10.1007/s00384-018-3198-0

Fig. 2.

Fig. 2

a Patients with high sICAM-1 concentrations present with a worse overall (p < 0.001) and cancer-related survival (p < 0.001) compared to patients with low sICAM-1 concentrations. b Combination of CEA and sICAM-1 serum concentrations identifies four significant (p < 0.001) different risk groups in CRC patients (n = 297). c Relative proportion in percent of UICC I–IV stages in patients with low and high sICAM-1 concentrations (left). Relative proportion in percent of UICC I–IV stages of combined sICAM-1/CEA score (right)